Entellus Medical (NSDQ:ENTL) said it paid $11 million in cash to acquire the XeroGel surgical sinus packing from Cogent Therapeutics. “We are pleased to secure ownership of this best-in-class nasal dressing technology as well as solidify control of the supply chain and distribution to our physician customers. We are excited about the opportunity to leverage our […]
Entellus Medical said today it expanded its distribution agreement with Fiagon NA to purchase and resell Fiagon’s surgical navigation systems, components and parts in the U.S. and its territories to now include hospitals. The expansion adds to the previous deal, inked last August, which made Entellus the exclusive distributor of certain Fiagon systems and parts to […]
Novartis pharma head Epstein steps away, most recent loss in string of top-level turnovers Novartis (NYSE:NVS) is facing an upheaval in its top management, seeing 7 departures over the last 5 months as shares fell 25% since last July. Last week, Novartis pharmaceuticals head David Epstein quit as his division was split up. Earlier in the month, U.S. […]
By Scott Wooldridge The climate for investment in medical device companies is improving but getting tighter, as biotech and pharma horn in on the recovering economy, according to a pair of medtech CEOs speaking at last night’s DeviceTalks: Minnesota event. Entellus Medical (NSDQ:ENTL) CEO Bob White and Martha Shadan, president & CEO at Rotation Medical, spoke with LifeScience Alley CEO Shaye […]
Entellus said earlier this month that it signed a distribution agreement with Fiagon NA Corp. to purchase and resell Fiagon’s surgical navigation systems, components and parts in the U.S. and its territories. The agreement will make Entellus the exclusive distributor of certain Fiagon systems and parts to ear, nose and throat physicians offices, clinics and surgery […]
NuVasive Inc. (NSDQ:NUVA) announced a flurry of new executive assignments yesterday as it reorganizes its leadership team under new CEO Gregory Lucier, who took over the position in May from ousted Alex Lukianov. NuVasive 14-year vet Pat Miles will stay on as COO and president, a position he was appointed to earlier this year, NuVasive said. […]
With 2014 a rebounding year for medical device and biopharmaceutical IPOs, 2015 should build further on that progress, a panel at the MedTech Investing Conference said this week.
Entellus Medical said yesterday that it plans to put nearly 4.4 million shares on the public markets by the end of the month as it readies its initial public offering.
Plymouth, Minn.-based Entellus said it plans to float 4.375 million shares at $15 to $17 each in the IPO, for a midpoint of $70 million.
Brian Farley knows a little something about building a successful medical device company from the ground up.
Back in 1995 Farley was the 1st employee of VNUS Medical Technologies, which developed a catheter-based treatment for venous insufficiency. During his tenure as VNUS CEO, the company went public in 2004 before being acquired by Covidien (NYSE:COV) for $440 million.